Histogen Inc logo

HSTO - Histogen Inc News Story

$0.793 -0.0  -2.1%

Last Trade - 24/09/21

Sector
Healthcare
Size
Micro Cap
Market Cap £24.2m
Enterprise Value £6.56m
Revenue £1.03m
Position in Universe 6262nd / 7172

Histogen Inc reports results for the quarter ended in March - Earnings Summary

Fri 14th May, 2021 2:24am
* Histogen Inc  HSTO.OQ  reported a quarterly adjusted loss
of 14 cents​​ per share for the quarter ended in March. The lone
analyst forecast for the quarter was for a loss of 15 cents per
share.
* Revenue was $431.00 thousand​;  analysts expected zero. 
* Histogen Inc's reported EPS for the quarter was a loss of 14
cents​.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Histogen Inc shares had fallen by 26.4% this quarter and
gained 26.3% so far this year.
* The company reported a quarterly loss of $4.27 million.
* Wall Street's median 12-month price target for Histogen Inc is
$5.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 1 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated May 14 at 01:24 a.m. GMT.
​All figures in US dollars
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.